Damoli Isacco, Butturini Giovanni, Ramera Marco, Paiella Salvatore, Marchegiani Giovanni, Bassi Claudio
General Surgery Unit B, The Pancreas Institute, Verona University Hospital Trust, Verona, Italy.
Wideochir Inne Tech Maloinwazyjne. 2015 Jul;10(2):141-9. doi: 10.5114/wiitm.2015.52705. Epub 2015 Jul 7.
During the past 20 years the application of a minimally invasive approach to pancreatic surgery has progressively increased. Distal pancreatectomy is the most frequently performed procedure, because of the absence of a reconstructive phase. However, middle pancreatectomy and pancreatoduodenectomy have been demonstrated to be safe and feasible as well. Laparoscopic distal pancreatectomy is recognized as the gold standard treatment for small tumors of the pancreatic body-tail, with several advantages over the traditional open approach in terms of patient recovery. The surgical treatment of lesions of the pancreatic head via a minimally invasive approach is still limited to a few highly experienced surgeons, due to the very challenging resection and complex anastomoses. Middle pancreatectomy and enucleation are indicated for small and benign tumors and offer the maximum preservation of the parenchyma. The introduction of a robotic platform more than ten years ago increased the interest of many surgeons in minimally invasive treatment of pancreatic diseases. This new technology overcomes all the limitations of laparoscopic surgery, but actual benefits for the patients are still under investigation. The increased costs associated with robotic surgery are under debate too. This article presents the state of the art of minimally invasive pancreatic surgery.
在过去20年中,微创方法在胰腺手术中的应用逐渐增加。由于无需重建阶段,胰体尾切除术是最常施行的手术。然而,胰中段切除术和胰十二指肠切除术也已被证明是安全可行的。腹腔镜胰体尾切除术被公认为是治疗胰体尾小肿瘤的金标准,在患者恢复方面比传统开放手术有诸多优势。由于切除极具挑战性且吻合复杂,通过微创方法对胰头病变进行手术治疗仍仅限于少数经验丰富的外科医生。胰中段切除术和剜除术适用于小的良性肿瘤,能最大程度保留实质。十多年前引入的机器人手术平台增加了许多外科医生对胰腺疾病微创治疗的兴趣。这项新技术克服了腹腔镜手术的所有局限性,但对患者的实际益处仍在研究中。与机器人手术相关的成本增加也在争论之中。本文介绍了微创胰腺手术的现状。